|
Market Closed -
Nasdaq
23:00:00 10/09/2026 +03
|
5-day change | 1st Jan Change | ||
| 6.520 USD | +2.35% |
|
+9.21% | -39.01% |
| 08-27 | Outlook Therapeutics Appoints Kevin Lundquist as CFO | MT |
| 08-14 | CapsoVision, Inc., Q2 2026 Earnings Call, Aug 13, 2026 |
| Market Cap | 326M 281M 265M 241M 451M 31.2B 455M 3.15B 1.21B 15.82B 1.23B 1.2B 50.26B | P/E 2026 * |
-11.6x | P/E 2027 * | -14.8x |
|---|---|---|---|---|---|
| Enterprise Value | 326M 281M 265M 241M 451M 31.2B 455M 3.15B 1.21B 15.82B 1.23B 1.2B 50.26B | EV / Sales 2026 * |
21.9x | EV / Sales 2027 * | 16.5x |
| Free-Float |
67.96% | Yield 2026 * |
-
| Yield 2027 * | - |
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| CV | Delayed | |
CBOE
| CV | Real-time | |
|
Deutsche Boerse AG
| H6U | Delayed |
Last Transcript : CapsoVision, Inc.
| 1 day | +2.35% | ||
| 1 week | +9.21% | ||
| Current month | +11.64% | ||
| 1 month | -2.40% | ||
| 3 months | -9.94% | ||
| 6 months | +25.63% | ||
| Current year | -39.01% |
| 1 week | 5.99 |  | 6.99 |
| 1 month | 5.75 | | 7 |
| Current year | 4.5 | | 11.37 |
| 1 year | 3.6 | | 15.37 |
| 3 years | 3.43 | | 15.37 |
| 5 years | 3.43 | | 15.37 |
| 10 years | 3.43 | | 15.37 |
| Manager | Title | Age | Since |
|---|---|---|---|
Kang-Huai Wang
CEO | Chief Executive Officer | 69 | 01/11/2024 |
David Garcia
DFI | Director of Finance/CFO | 52 | - |
Keri Jorgenson
PRN | Corporate Officer/Principal | - | 01/03/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Kang-Huai Wang
BRD | Director/Board Member | 69 | 01/11/2024 |
Chen Lung Tsai
CHM | Chairman | 74 | 01/01/2025 |
Hui Ying Kuo
BRD | Director/Board Member | 55 | 01/02/2024 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 7/17/26 A | Buy | Director | 61,068 | 0.1225% | ||
| 7/8/26 A | Buy | Director | 81,300 | 0.1631% | ||
| 7/1/26 A | Free | Director | 1,710 | 0.0034% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.35% | +9.21% | +79.61% | - | 326M | |
| -1.10% | -2.59% | -32.79% | -3.53% | 12.47B | |
| +0.10% | -2.67% | +14.88% | +12.26% | 4.22B | |
| -2.44% | +2.68% | -44.78% | -53.01% | 1.26B | |
| +0.38% | -4.62% | -42.76% | -41.78% | 1.1B | |
| -2.02% | -5.45% | +14.47% | +73.42% | 1.05B | |
| -2.49% | -4.91% | -39.59% | - | 976M | |
| -3.32% | -8.14% | - | - | 967M | |
| -2.08% | -2.12% | +34.20% | +107.42% | 510M | |
| +3.39% | -0.14% | -68.24% | +294.78% | 236M | |
| Average | -0.72% | -2.30% | -9.44% | +55.65% | 2.31B | |
| Weighted average by Cap. | -1.00% | -3.99% | -20.12% | +4.62% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 14.87M 12.79M 12.07M 10.99M 20.55M 1.42B 20.74M 144M 55.32M 721M 55.85M 54.63M 2.29B | 19.82M 17.05M 16.08M 14.65M 27.39M 1.9B 27.64M 192M 73.73M 961M 74.44M 72.81M 3.05B |
| Net income | -27.56M -23.7M -22.36M -20.37M -38.08M -2.63B -38.42M -266M -102M -1.34B -103M -101M -4.24B | -22.1M -19.01M -17.93M -16.34M -30.54M -2.11B -30.82M -214M -82.2M -1.07B -82.99M -81.18M -3.4B |
| Net Debt | - | - |
Employees
99
| Date | Price | Change | Volume |
|---|---|---|---|
| 10/09/26 | $6.520 | +2.35% | 163,623 |
| 09/09/26 | $6.370 | +0.16% | 185,251 |
| 08/09/26 | $6.360 | +6.18% | 391,401 |
| 04/09/26 | $5.990 | +0.34% | 38,501 |
| 03/09/26 | $5.970 | +0.67% | 62,720 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
6.520USD
Average target price
9.500USD
Spread / Average Target
+45.71%
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- CV Stock
Select your edition
All financial news and data tailored to specific country editions
